drugset / Trial / NCT06222437
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the effect of semaglutide in women with Polycystic Ovarian Syndrome(PCOS ) and determine potential therapeutic benefits.
Timeline
- Start
- 2026-02
- Primary completion
- 2026-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | — | — |